valo health crunchbase. Operating Status Active. valo health crunchbase

 
 Operating Status Activevalo health crunchbase  Headquarters Regions European Union (EU), Nordic Countries, Scandinavia

$58. Search Crunchbase. Valo Therapeutics has raised a total of. 6, 2020 /PRNewswire/ -- Valo Therapeutics Limited (Valo Tx), an immuno-oncology company developing tumour. This presentation (“Presentation ”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between Khosla Ventures Acquisition Co. Amount. Announced Date Nov 1, 2019. I. Contact Email info@neurahealth. “Crunchbase Pro is a tool we can use to scale our lead generation process. Valo Health, LLC ("Valo") is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. BOSTON, Nov. CB Rank (Hub) 16,879. 6. com. Operating Status Active. Percentage of Public Organizations 2%. today announced they have entered into an agreement to discover and develop novel. Legal Name Calibrate Health, Inc. Industries Venture Capital. About Valo Health . Number of Founders 494. Phone Number 848-272-1140. We’re focused on bringing together the brilliant minds of Data Platform experts, Software Engineers, Early Discovery Chemistry aficionados, Preclinical. Food and Drug Administration for its second generation point of. Last Funding Type Private Equity. Legal Name PathAI, inc. Phone Number 201-632-1152. Integral Health Corporate Development Mar 2019. In 2018 was created Valo Ventures, which is appeared as VC. Koch Disruptive Technologies Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities. Date. Phone Number 49 4795 957 2020. Valo — Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs Details of Initial Therapeutic Programs to be Shared at the 39th J. Founded in 2006, Chicago-based Outcome Health (formerly ContextMedia) delivers better health outcomes and impacts the human condition positively through technology. Publication Summary: The Food, Drug and Cosmetic Act grants the Food and Drug Administration plenary authority over. Valo Health EVP & CFO Aug 2020. Percentage Non-Profit 11%. Location Boston, Massachusetts, United States. Carrot Health helps healthcare payers and providers increase market share, improve loyalty, and strengthen engagement. Phone Number (614)846-4318. Phone Number (888) 880-1664. Boston-based RA Capital Management and New York-based OrbiMed ranked first and second, respectively, on the two lists compiled using Crunchbase data. Stockholders of record as of the close of business on October 13, 2021 are entitled to vote at the Special Meeting. Updated Feb 24, 2021 6:01pm EST. Software. David Berry to Participate in NewYorkBio and New York Stock Exchange Emerging Biotech Company Showcase. 8 billion. Operating Status Active. That’s up by just under $110 billion compared to the previous half-year record that was just set in the second half of 2020. Valo Therapeutics. Investor search resultsFunding Round search resultsThe company reported 97% year-over-year growth in annual recurring revenue (ARR) for the quarter, as well as 153% year-over-year growth in net new ARR for 2021. Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform the drug discovery and development process. $2. November 10, 2021. 4mo. Company Type Non-profit. 7B Total Funding Amount • 2,857 Number of Investors. Additionally, Guido Lanza has had 1 past job as the CEO at Numerate. Legitimate emails from Valo employees end in “@valohealth. The company has doubled each year in its scale of technology implementation at outpatient healthcare. Contact Email [email protected] Disclaimer. Search Crunchbase. Valo Health acquires TARA Biosystems on 2022-04-05 for an undisclosed amount. Legal Name Virta Health Corp. in funding over 4 rounds. Contact Email contact@arrivehealth. Hemanshu Shah is the Chief Business Officer of Valo Therapeutics. Previous Next. Acquisition Status Complete. Monitor Industry Trends. This presentation (“Presentation ”) is for informational purposes only to assist interested parties in making their own evaluation with respect to the proposed business combination (the “Business Combination”) between Khosla Ventures Acquisition Co. BOSTON, MA (March 9, 2021) — Valo Health LLC (Valo), a tech­nol­o­gy com­pa­ny trans­form­ing the drug dis­cov­ery and devel­op­ment process and seek­ing to accel­er­ate the. Last Funding Type Series A. Start Free Trial . Dawn Health is a digital health company offering life-changing digital health therapies driving. Phone Number (415) 941-5734. Organization Name. Editor’s note: This story is Part three of our series spotlighting late-stage startups that not only raised big funds recently but doubled their valuations as well. Boston, MA (June 2, 2022) Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence, announced a proof of con­cept for using its pre­clin­i­cal asset, OPL-0101, to tar­get CD 8 + T cells, in the cur­rent issue and fea­tured on the cov­er of. At Catalyst Partners, Seth is helping g. Company Type For Profit. We can go from zero to a molecule in hand in as little as 3 weeks. A formal recruitment process, including an interview with a member of the recruitment team, is required to gain an offer of employment from Valo. Seth is an entrepreneur and financial professional focused on the execution of transformative ideas. Start Free Trial . Valo Health raised $100000000 on 2019-07-01 in Series A. 6M See more info on. Careers. The Company was incubated and is backed by L Catterton, the. Medical. in funding over 5 rounds. Company Type For Profit. Location San Francisco, California, United States. includes any. Legal Name HDO Health, LLC. Phone Number (+91)9005008946. Company Type For Profit. Start Your Free Trial . Operating Status Active. Valo Health. Company Type For Profit. com. 6. Average Founded Date Mar 5, 2005. eFFECTOR is a clinical stage biopharmaceutical company focused on pioneering the development of a new class of. Company Type For Profit. ” IN CONNECTION WITH THE BUSINESS COMBINATION DESCRIBED HEREIN) On June 9, 2021, we entered into an Agreement and Plan of Merger with Killington Merger Sub Inc. Company Type For Profit. CB Rank (Hub) 24,371. As a. Valo Health raised $100000000 on 2019-07-01 in Series A. Legal Name Vida Health, Inc. Title At. Valo is located in Delhi, Delhi, India. Location San Francisco, California, United States. Twin Health is a Precision Health platform combining Sensors,. Industry Groups Financial Services, Lending and Investments. Founders Christopher McCann, Stewart Whiting. Khosla Ventures Acquisition Co. Phone Number +34951255080. Industry Groups Health Care. Resources. In one mobile app, Varo offers customers no-cost premium bank accounts and. Additionally, Guido Lanza has had 1 past job as the CEO at Numerate. Medical. Operating Status Active. Log In. Valo Health. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users. BOSTON, April 5, 2022 /PRNewswire/ -- Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. Company Type For Profit. Pricing. Location Boston, Massachusetts, United States. Founded Date 2014. Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women SAN JOSE, Calif. BOSTON, April 5, 2022 -- Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. Solutions. Twitter View on Twitter. Founders Sigurjon Kristjansson. Additionally, Ilya Rekhter has had 1 past job as the Co-Founder & CEO at DoubleMap. Also Known As Trifork eHealth ApS. Last Funding Type Seed. Acquisitions 1. Company Type For Profit. To grow from 100 to 1,000 customers, we have to segment our prospect base, find similar companies and. Contact Email partnerships@valohealth. ”. Valo raises $190m, unveils cancer drugs: Boston-based Valo Health announced on Monday it has raised $190 million in its second round of funding. Included Health is funded by 8 investors. SolutionsEvent search resultsIncreased investing pace. Top Funding Types Seed , Venture - Series Unknown , Pre-Seed , Grant , Series A. Flo prioritizes safety and keeps a sharp focus on being the most trusted. Industry Groups Health Care. The Carlyle Group and Adams Street Partners are the most recent investors. Company Type For Profit. Operating Status Active. ”. 7 billion, with $14. Nourished is the first company in the nutrition industry to offer truly personalised vitamin gummies. Tally Health™ is a biotechnology company founded to change the way we age. Valo will receive $60 million up front, and could get. 4, 2021 /PRNewswire/ -- Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery, development, and delivery process, today announced the appointment of Joe Chan as its Head of Engineering. . Valo's main R+D centre is located in Málaga, Spain. Molecule Design. . Valo Health, LLC. Last Funding Type Grant. We identify and support entrepreneurs who are applying digital technologies. Acquisition Status Complete. SolutionsEvent search resultsAbout. Products. Valo | Team Company Leadership We are driven to find better, bolder approaches to drug discovery that will ultimately transform the way we think about disease. , a special purpose acquisition company from Khosla Ventures. Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and. Who are Valo 's competitors? Alternatives and possible competitors to Valo may include Voura , Eiloy , and V. Valo Health will be attending Canaccord Genuity's 43rd Annual Growth Conference, August 7-10, 2023, in Boston. Valo Health: Founded: 2019 Headquarters: Boston, Massachusetts. Featuring Daniel E. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Twitter View on Twitter. We are a full-stack AI biotech. Operating Status Active. Operating Status Active. Contact Email info@hazel. Valo Therapeutics is funded by 2 investors. Be part of a culture that emphasizes trust and diversity, where people are generous with their ideas, support their colleagues, and feel free to voice their opinions. Contact Email info@dispatchhealth. Contact Email bstewart@hdohealth. , March 14, 2023 /PRNewswire/ -- Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U. Resources. Valo will receive $60 million up front, and could get. 2B Total Funding Amount • 1,236 Number of Investors. Valo Health is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. BOSTON, March 9, 2021 /PRNewswire/ -- Valo Health LLC (Valo), a technology company transforming the drug discovery and development process and seeking to accelerate the. 8 billion. com. Organization Name. 5 million. Operating Status Active. Pricing. Valo Health. Number of Past Jobs 2. Operating Status Active. The platform allows home care agencies to deliver mixed. Company Type For Profit. Vivante Health is funded by 14 investors. Behavioral health practices have different documentation, scheduling, and billing needs compared to primary care and other medical specialties. au. Chrome Extension. Connor Campbell is the Co-Founder and CEO of Osler. Phone Number 208-365-3561. com. Vivante Health has raised a total of. News • Jan 11, 2021. We identify and support entrepreneurs who are applying digital technologies. The company's platform integrates machine learning, cloud computing, and data to analyze human data to uncover previously unsuspected associations between genetic markers and disease with a human-centric framing, enabling the healthcare industry to. Founded Date Jan 1, 1993. Founded Date 2017. We are thankful to the Ohana team, patients, clinicians | As of Friday. Pricing. Our health and lives are at stake. (NYSE: CRL) today announced a multi-program agreement with Pioneering Medicines, a. Contact Email [email protected] 2022, Charles River and Valo Health, Inc (“Valo”) launched Logica, leveraging Valo’s AI-powered Opal Computational Platform and Charles River’s leading preclinical expertise, providing clients with transformed drug discovery with a single integrated offering seamlessly translating targets to candidate nomination. Contact Email [email protected] 26, 2023 at 6:36 AM · 4 min read. Legal Name Numerate, Inc. We are focused on generating and applying evidence. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. 6M. Manufacturing. Montai is aggregating the world's largest, fully-annotated knowledge graph of Anthromolecule chemistry - privileged molecules that have co-evolved with humans for thousands of years through exposure to food, herbs, and traditional medicines. Also Known As AireSone. Additionally, Graeme Bell has had 2 past jobs including Executive Vice President and Chief Financial Officer at Tmunity Therapeutics. With unique funding data and other insights, Crunchbase Enterprise is the best way for us to create targeted lists of newly-funded accounts that are ready to buy. Legal Name Rupa, Inc. com. Regions San Francisco Bay Area, West Coast, Western US. Number of Current Jobs 2. Edit Overview Section. Medical. Previous Next. ("Valo") is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. Investors 5. Operating Status Active. 14, 2022 / PRNewswire/ — Valo Health, Inc (“Valo”) shared the ini­tial results of a col­lab­o­ra­tive study with the U. Log In. Charles River isn’t the only believer in Valo. com. Company Type For Profit. Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life-changing cures. com. Valo General Information. 1,946 Number of Organizations • $17. Announced Date Oct 5, 2021. Valo is a new. Software. He serves on the boards of Flagship-founded companies including Seres Therapeutics (NASDAQ: MCRB) and Valo Health. Jennifer Hanley has 2 current jobs as Head of Corporate Communications at Valo Health and Director of Global Communications and Corporate Engagement at Kohlberg Kravis Roberts. Hub Tags Unicorn. Their latest funding was raised on Sep 9, 2020 from a Series E round. Company Type For Profit. BOSTON, May 8, 2023 — Valo Health, Inc. Company Type For Profit. A. Provides fast. VALO’s products and services provide better lighting for city inhabitants which increases safety. CB Rank (Hub) 11,433. BioSpace — Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs. After Fund VII’s close, Flagship is now operating with an aggregate capital pool of $6. It aims to create an integrated, convenient, triage, and. 1. Lighting. Contact Email [email protected] Health overview Valo Health a technology company that is using human-centric data and machine learning-anchored computation to transform and accelerate the drug discovery and development process. Last Funding Type Series B. June 9 (Reuters) - Boston-based Valo Health LLC said on Wednesday it would go public through a merger with a blank-check firm backed by prominent venture capitalist Vinod Khosla, in a deal valuing. CB Rank (Person) 1,113,637 Primary Job Title Software Engineer; Primary OrganizationCombined Company to Spearhead Transformation of Cardiovascular Disease Drug Discovery and Development. Unlock for free. Contact Email info@valobiomedia. Mercato Partners and SemperVirens Venture Capital are the most recent investors. This fund was announced on Jun 13, 2019 and raised a total of . Founded Date 2019. Valo Health's latest funding round was a Series B - II for $110M on March 9, 2021. Companies Contacts Investors Funding Rounds Acquisitions People Events Schools Hubs Saved Press References . Operating Status Active. 6M. Company Type For Profit. At that time, the plan was to combine $250 million from Valo, $333 million from the SPAC. Company Type For Profit. Operating Status Active. Phone Number +61 1300 153 338. 208. Valo has created a unique “closed-loop” active learning, self-reinforcing, in silico and in lab-experimental platform that rapidly iterates to design drugs, making targeted and specific small molecules ‘engineerable’. Valo Ventures has made 32 investments. DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes. com. Last Funding Type Grant. Number of Past Jobs 1. Last Funding Type Series A. Company Type For Profit. Founded Date 2014. Founded in 2019 it came out of stealth mode in September 2020. in funding over 7 rounds. At that time, the plan was to combine $250 million from Valo, $333 million from the SPAC. Operating Status Active. Law Enforcement. Los Angeles Startups. With Hazel, students can talk with a doctor over the video. At Kite, our singular focus is cell therapy to treat and potentially cure cancer. Unlock the Insights You Need with Crunchbase. SaVia Health develops software that provides real decision support to clinicians at the point of care. Legal Name Pluto Health, Inc. BOSTON, July 27, 2021 / PRNewswire/ — Valo Health, LLC (“Valo”), the tech­nol­o­gy com­pa­ny built to trans­form the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence-dri­ven com­pute, today announced its acqui­si­tion of Couri­er Ther­a­peu­tics. Last Funding Type Series B. Their latest funding was raised on Sep 20, 2023 from a Series B round. Investors. Careers. Search Crunchbase Start Free Trial Headquarters Regions San Francisco Bay Area, West Coast, Western US. As of Friday, April 30, Ohana Biosciences will cease operations. Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. Last Funding Type Series C. Valo Health. Percentage Non-Profit 11%. Machine Learning. com. Percentage Non-Profit 1%. Resources. VALO is a smart city integrator that aims to better people’s lives around the world through the Internet of Things (IoT) technology. 8,295 Number of Organizations • $85. Founded Date Jul 13, 2016. 75 million users—including salespeople, entrepreneurs, investors, and market researchers—use. Funding Stage Late Stage Venture. Founded Date Jun 2020. Valo Health VP of Innovation Nov 2019. Vida Health is a virtual care platform intentionally designed to treat a person’s whole health by treating. Valo Health uses human-centric data and machine learning-anchored computation to transform the drug discovery and development process. 11, 2021 /PRNewswire/ -- Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of. Contact Email support@helloseason. Crunchbase | Website | Twitter | Facebook | Linkedin. 4mo. com. Number of Past Jobs 2. Hospitality Companies With More Than $1M in Revenue. Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. Headquarters Regions European Union (EU), Nordic Countries, Scandinavia. Valo Health, LLC (Valo) is a technology company that is using human-centric data and machine learning-anchored computation to transform and accelerate the drug discovery and development process. Phone Number 8589258215. Logica uses Valo's Opal computational platform and Charles River's preclinical expertise to provide advanceable. Legal Name Nox Health Group, Inc. Pricing. Regions East Coast, Northeastern US. Legal Name eFFECTOR Therapeutics, Inc. Koch Disruptive Technologies Koch Disruptive Technologies is a venture capital firm that invests in technologies to improve businesses and create new opportunities. Acquisition Status Complete. About Valo Health . com. Valo Health, a drug discovery company that launched less than a year ago, is joining the public markets through a merger deal that values the firm at about. Phone Number 415-854-6366. Operating Status Closed. Global venture capital funding in the first half of 2021 shattered records as more than $288 billion was invested worldwide, Crunchbase numbers show. Valo Ventures is a thesis-driven venture capital firm investing in North America and Europe. “Crunchbase Pro is a tool we can use to scale our lead generation process. CB Rank (Hub) 17,181. Pyxis Oncology. health tech company Valo Health struck a deal to use AI to find treatments for cardiometabolic diseases. VOS. Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery. Percentage of Public Organizations 2%. Operating Status Active. Operating Status Active. Operating Status Active. Contacts 121. Percentage Acquired 3%. Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health. News • Jan 11, 2021. Ilya Rekhter has 4 current jobs including Manager at TripleMap Ventures, Investor at Perceivant, and Investor at Senda Biosciences. Track. June 7, 2023 • Valo Health View all Publications. Last Funding Type Post-IPO Equity.